Fortescue Metals Group (OTCQX: FSUMF) faces executive turnover, infrastructure issues, and waning investor confidence, suggesting a difficult year ahead.
Nexalin Technology has received U.S. patent for its non-invasive Deep Intracranial Frequency Stimulation device for Alzheimer's and dementia. The device is part of a market projected to reach over $28 billion by 2030.